SA PRO
Free Account
Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 86% recommend buying.

Consensus Rating
Buy
7 analysts·Limited coverage
86%
Rating Distribution
Strong Buy
00%
Buy
686%
Hold
114%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 24, 2025H.C. Wainwright
Benitec Biopharma price target lowered to $32 from $35 at H.C. Wainwright
Target:$32.00
+141.3%from $13.26
Nov 4, 2025H.C. Wainwright
Benitec Biopharma price target raised to $35 from $28 at H.C. Wainwright
Target:$35.00
+123.1%from $15.69
Nov 4, 2025JMP Securities
Benitec Biopharma price target raised to $22 from $20 at Citizens JMP
Target:$22.00
+38.7%from $15.86
Sep 16, 2025Oppenheimer
Benitec Biopharma price target lowered to $29 from $35 at Oppenheimer
Target:$29.00
+112.3%from $13.66
Oct 14, 2024JMP Securities
Benitec Biopharma price target raised to $18 from $16 at JMP Securities
Target:$18.00
+65.7%from $10.86
Oct 14, 2024JMP Securities
Benitec Biopharma price target lowered to $16 from $18 at JMP Securities
Target:$16.00
+47.3%from $10.86
Oct 14, 2024Leerink Partners
Leerink Partners Reiterates Outperform Rating on Benitec BioPharma (BNTC)
Target:$13.00
+19.7%from $10.86
Sep 24, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on Benitec BioPharma (BNTC)
Target:$30.00
+237.8%from $8.88

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance